ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Identification of proteins interacting with ALK in neuroblastoma. | Dana-Farber Cancer Institute / Rani George | Young Investigator Grants | 2009 | Massachusetts |
| Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors | Children’s National Medical Center / Suzanne Miles | Young Investigator Grants | 2009 | District of Columbia |
| MLL-based chromosomal translocations in the pathogenesis of childhood leukemia. | Children’s Mercy / Erin Guest | Young Investigator Grants | 2009 | Missouri |
| DFMO-based combination therapy for the treatment of advanced stage neuroblastoma. | Cancer Research Center of Hawaii / Dana-Lynn Koomoa | Young Investigator Grants | 2009 | Hawaii |
| Biology-based clinical trials for children with cancer. | Children’s Hospital of Philadelphia / Rochelle Bagatell | Phase I/II Infrastructure Grants | 2009 | Pennsylvania |
| Development of a childhood leukemia translational research program. | Dana-Farber Cancer Institute / Lewis Silverman | Phase I/II Infrastructure Grants | 2009 | Massachusetts |
| Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado. | Children’s Hospital Colorado / Lia Gore, MD | Phase I/II Infrastructure Grants | 2009 | Colorado |
| Targeting wnt in synovial sarcoma models. | Vanderbilt University Medical Center / Josiane Eid | Innovation Grants | 2009 | Tennessee |
| Adaptation of acute lymphoblastic leukemia (ALL) to the post-transplant allogeneic environment. | University of Rochester / Craig Mullen | Innovation Grants | 2009 | New York |
| BH3 profiling to define therapy resistance classes in neuroblastoma. | Children’s Hospital of Philadelphia / Michael Hogarty | Innovation Grants | 2009 | Pennsylvania |